Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02037685 · ClinicalTrials.gov registry record · NA
Improving Adherence to Statins Among Minority Populations
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 779
- Enrollment target
NCT02037685: Completed NA study, sponsored by University of Miami.
NCT02037685 is a NA study that has completed, run by University of Miami. The registered enrollment target is 779 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02037685, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 779 participants
- Enrollment target
Study Summary
Statins are cholesterol lowering medications that reduce the risk of cardiovascular events. However adherence to these medications has been found to be lower among minorities, a group particularly vulnerable for heart disease. The purpose of this study is to compare the efficacy of a phone based behavioral intervention to mailed educational materials regarding how to control cholesterol and other risk factors. We hypothesized that the behavioral intervention will improve adherence to statins by 15%.
Primary Outcome
The primary outcome will be MPR for statin medication equal or above .80. MPR is a continuous multiple interval measure of medication availability. The medication possession ratio is defined as the sum of the days' supply of medication divided by the number of days between the enrollment and the last day of follow up. The binary dependent variable is: MPR equal to or above .80 (adequate adherence or drug availability during 80% or more of the therapy time) and MPR below .80 (non adherence or dru
Interventions
- OTHER Usual Care
- BEHAVIORAL Motivational Interviewing (MINT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 779 participants |
| Start Date | 2010-06 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02037685 record still lists
NCT02037685 is an interventional study that assigns participants to a tested intervention. The registered 779 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02037685 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02037685 about?
NCT02037685 is a clinical study titled "Improving Adherence to Statins Among Minority Populations". Statins are cholesterol lowering medications that reduce the risk of cardiovascular events. However adherence to these medications has been found to be lower among minorities, a group particularly vulnerable for heart disease. The purpose of this study is to compare the efficacy of a phone based be...
What is the current status of trial NCT02037685?
This trial is currently completed. It is a NA study. The enrollment target is 779 participants. The study started on 2010-06. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02037685?
The interventions under investigation include: Usual Care (OTHER), Motivational Interviewing (MINT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02037685?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02037685's enrollment target sits among peer trials
779 142nd of 2000 higher than 1,859 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
- NCT05513872 · 780 participants · Phase 1
Overcoming Nicotine Dependence to Enable Quitting
- NCT06310031 · 780 participants · NA
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia